Investor Home
Fact Sheet
Stock Information
SEC Filings
Financial Reports
Corporate Governance
Code of Conduct
Request Information
Press Releases
Calendar of Events
Earnings Estimates
E-mail Alerts

OrthoLogic is a biotechnology company focused on the development and commercialization of the novel synthetic peptide Chrysalin® (TP508) in two lead indications, both of which represent areas of significant unmet medical need – fracture repair and diabetic foot ulcer healing. Based on the Company’s pioneering scientific research of the natural healing cascade, OrthoLogic has become a leading company focused on tissue and bone repair. The Company owns exclusive worldwide rights for Chrysalin... More >>

Stock Quote
OLGC (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.06 (7.23%)
Data as of 05/26/10 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Featured Report
Annual Report
Recent News More >>
There are currently no news releases.
Contact Information
Primary IR Contact
Investor Relations Contact
Phone: 602–286-5250

Transfer Agent
The Bank of New York

Phone: 1-800-524-4458

Data provided by Nasdaq. Minimum 15 minutes delayed.
Home   |   About   |   R & D   |   Investor Relations   |   Career Info   |   Contact Us
copyright © 2004 OrthoLogic. All Rights Reserved.  |   Privacy Practices  |   Legal Disclaimer